Julian Cuartero-Borras
Castello De La Plana, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Severe Rituximab-Induced Cytokine Release Syndrome After Desensitization Successfully Treated With Tocilizumab: A Case Report.
Journal: Journal of investigational allergology & clinical immunology
Published: June 25, 2026
Comparison of rapid and same-day desensitization protocols in hypersensitivity reactions to platinum and taxanes: a retrospective cohort study.
Journal: Frontiers in allergy
Published: November 21, 2025
Laryngopharyngeal dysesthesia as a possible clinical manifestation of a cytokine release reaction due to oxaliplatin.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 15, 2025
Cytokine Release Reaction After Subcutaneous Daratumumab: Possible Relationship With Hymenoptera Allergy.
Journal: Journal of investigational allergology & clinical immunology
Published: April 25, 2025
The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center.
Journal: Frontiers in allergy
Published: August 12, 2024
Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis.
Journal: Journal of investigational allergology & clinical immunology
Published: January 26, 2024
Anaphylactic Shock due to Isatuximab and Successful Desensitization.
Journal: Journal of investigational allergology & clinical immunology
Published: October 09, 2023
Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents.
Journal: Frontiers in allergy
Published: February 02, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026